Member Info for mazik

Well oversold, is there update due?

Mask will be essential due to deadly mutant virus..imo

This will be rerated considering the economics fallback in the world..

Will not be surprised, even then its a buy :-)

Mask is a must for years to come..IMO

Expru please keep your rocket to yourself, at best partnering with Pfizer to deliver normal room temperature or at oral delivery which will take time, at best news of phase3 result from Evotec. Nigel should come out the stage we are with Nuvec as a delivery system with the majors Az or Biontec.. (Shut up or Put up) Hurry up now we have deadly mutant variant...Nigel News please.

Homer1234 " Thankful" yes we have many surprises from this lot.... Good luck

Brighty1 save your intelligence, please do not put a spin on this aimless 7am RNS.

What a load of shower? Non executive Director is doing his job counting "the total number of ordinary shares and voting rights in the Company is currently 181,080,349." This is a New Years Joke from N4P Management" A Rns stating Happy New Year would have been better" GLA

Main Listing Mcap ??? a lot happening here

Market Cap under £4 million, for a Mail listing O&G and Tunisia deal in the pipeline feel that should be more like market cap of £10 million plus IMO

G-Man11, just an opinion , if I had to depend on making profits on investment of £50k plus on someone tweets I rather give up.
I am here only as there is need of Nuvec as a vaccine delivery system , feel Market cap of £13 million is well oversold. IMO
As Nigel has stated on the last 2 RNS that a collaboration and partnership is an option with the likes of Pfizer or AZ...Patience needed here.
To recap vaccine efficacy is predominantly determined by the selected nucleic acid antigen, having a stable, easy to store and easy to use vaccine is crucial in helping vaccine acceptance and uptake. A formulation stable at room temperature or even refrigerated can represent significant cost savings in vaccine transportation, storage and administration. We believe, to the extent that Nuvec® as a delivery platform can provide a solution in this area, it could be of significant interest to multiple vaccine developers.

G-Man thanks dont need tweets from the likes of "Rodney or Myles" last time bragging he sold down at 14p , so he can buy at 8p placing price....

Expect news within coming days " vaccine efficacy is predominantly determined by the selected nucleic acid antigen, having a stable, easy to store and easy to use vaccine is crucial in helping vaccine acceptance and uptake. A formulation stable at room temperature or even refrigerated can represent significant cost savings in vaccine transportation, storage and administration. We believe, to the extent that Nuvec® as a delivery platform can provide a solution in this area, it could be of significant interest to multiple vaccine developers. As this statement I will be surprised our market cap is just £13m, should be £50m plus.... GLA

The most important is to resolve the mutant factor which the Nuvec can resolve being mnRna delivery system..we have a massive potential if Pfizer selects for the logistics of its Vaccine..

Sorry meant Pfizer vaccine requires -70C

Any JV with us....life changing result for N4p holders IMO..within year 2021 if we achieve Oral solution..the big IF N4p mcap of £500m as a starter.

G-man11 absolutely right, expecting news from Nigel sooner than later, and we expect its a race between Pfizer and Astra Zeneca, already setback with Pfizer maintaining -17c in Northampton was a waste due to freezer problem creating a logistic nightmare with all the other problem with maintaining immunity. Feel we have news in front us regarding partnership with focus on Nuvec...

Az Vaccine will be given go ahead within two weeks for mass vaccination..its logistically viable ensuring room temperature...now most importantly we will know as how Nuvec status will stand in front of its requirement..Expect news in coming days...gla

maidit380 thank u , have all of u have a merry Xmas...looking forward to keep adding to my ISA here in the new year.